$LXRP - StockHouse Interview: From COVID to Nicot
Post# of 4861
(Total Views: 224)
Posted On: 12/03/2020 9:52:49 AM
$LXRP - StockHouse Interview: From COVID to Nicotine Treatments, this Bio Stock is One to Watch Lexaria Biosciences Inc.
Stockhouse – 1 day ago
There’s no shortage of excitement over potential COVID-19 vaccines. Just looking at the response to news around these developments is evidence of that, and one Company is working on a transformative, patented technology platform that’s fast acting, less expensive and a more effective oral drug delivery to treat such diseases as Coronavirus, or even to disrupt the $990 billion global nicotine market.
https://stockhouse.com/opinion/interviews/202...e-to-watch
Stockhouse – 1 day ago
There’s no shortage of excitement over potential COVID-19 vaccines. Just looking at the response to news around these developments is evidence of that, and one Company is working on a transformative, patented technology platform that’s fast acting, less expensive and a more effective oral drug delivery to treat such diseases as Coronavirus, or even to disrupt the $990 billion global nicotine market.
https://stockhouse.com/opinion/interviews/202...e-to-watch
(2)
(0)Scroll down for more posts ▼